Shock: Clinical Trials

25 trials for Shock, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 unknown. 25 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 425Unknown 25

Follow Shock: new trials by email Literature Review of Shock trials Research Report on Shock

Trials (filtered) newest first · largest first

All 25 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Bedtime Melatonin in Critically Ill Patients
Oral Bedtime Melatonin, Placebo suspension or capsule - Septic Shock, Stroke Hemorrhagic
Phase 4UnknownHospital San Carlos, Madrid1602025-02-012024-03-01
Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock
vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.25 mcg/kg/min, vasopressin infusion when the norepinephrine dosage is equal to or greater than 0.5 mcg/kg/min - Septic Shock, Renal Function Replacement
Phase 4UnknownAzienda Usl di Bologna2642024-05-152024-06-24
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
Initiation of vasopressine as a first vasoconstrictive drug, Initiation of noradrenaline as a first vasoconstrictive drug - Circulatory Shock
Phase 4UnknownUniversity of Thessaly1452023-12-152024-03-06
Hemodynamic Response to Angiotensin-II When Used as the Second Vasopressor Agent for Septic Shock
Angiotensin II and hydrocortisone sodium succinate - Septic Shock, Shock
Phase 4UnknownKingman Regional Medical Center502023-12-042024-05-23
The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients
norepinephrine+vasopressin, Norepinephrine - Septic Shock
Phase 4UnknownPeking Union Medical College Hospital602023-05-012023-06-02
Role of Ulinastatin in Preventing Severe Sepsis and Consequent Morbidities and Mortality
Ulinastatin - Severe Sepsis, Septic Shock
Phase 4UnknownJinnah Postgraduate Medical Centre1752023-05-012023-06-08
Cytokine Guided Risk Stratification and Treatment in Pediatric Hemophagocytic Lymphohistiocytosis
Dexamethasone, Etoposide, Ruxolitinib - Hemophagocytic Lymphohistiocytoses, Cytokine Storm
Phase 4UnknownThe Children's Hospital of Zhejiang University School of Medicine4002022-09-012022-10-06
20% Albumin vs. Balanced Salt Solution as Resuscitation Fluid in Cirrhosis With Sepsis Induced Hypotension
20% albumin, Balanced salt solution - Cirrhosis, Liver, Acute-On-Chronic Liver Failure
Phase 4UnknownPost Graduate Institute of Medical Education and Research, Chandigarh1502020-08-152022-07-01
Low-chlorine Vs High-chlorine Crystalloids in Septic Shock Adults
Sodium Bicarbonate Ringer's Injection, 0.9% Sodium Chloride Injection - Septic Shock
Phase 4UnknownSoutheast University, China1002020-05-012020-04-28
The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation
Tocilizumab - Covid19 Pneumonia
Phase 4UnknownHadassah Medical Organization5002020-04-082020-05-06
Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study
Terlipressin, Placebo - Septic Shock
Phase 4UnknownAssistance Publique Hopitaux De Marseille402018-07-272018-11-29
Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock
Ivabradine Oral Tablet, Standard of Care treatment - Cardiogenic Shock
Phase 4UnknownHospital Universitario Ramon y Cajal222018-05-012018-02-19
Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine
Ivabradine, Placebo - Heart Failure, Cardiogenic Shock
Phase 4UnknownLoyola University402018-03-152019-05-23
Dex on Microcirculation in SS-A Double-blinded Study
Dexmedetomidine for dexmedetomidine group - Septic Shock
Phase 4UnknownSoutheast University, China442016-01-012017-06-15
Effects of Levosimendan, Milrinone and Norepinephrine on Left and Right Ventricular Function in Septic Shock
Norepinephrine, Milrinone, Levosimendan - Septic Shock, Cardiomyopathy
Phase 4UnknownSahlgrenska University Hospital302015-12-012018-11-29
Early Goal Directed Sedation on Microcirculation in Septic Shock
Dexmedetomidine for sedation - Septic Shock
Phase 4UnknownSoutheast University, China252015-11-012016-04-20
The Pharmacokinetics of Fentanyl in Intensive Care Patients
Fentanyl - Multiple Organ Failure, Critical Care
Phase 4UnknownOslo University Hospital1502015-10-012015-10-29
Botulinum Toxin A for Treatment of Catocholamine Induced Finger Necrosis
Botox, Placebo - Catocholamine Induced Finger Necrosis
Phase 4UnknownSheba Medical Center202012-01-012012-01-05
Chloride High Level Of Resuscitation Infusion Chloride High Level Of Resuscitation Infusion Delivered Evaluation
Lower chloride fluids (Hartmann's solution and Plasmalyte®) - Shock, Critical Illness
Phase 4UnknownAustin Health70002009-02-012010-02-25
Early Continuous Renal Replacement Therapies (CRRT) in Patients With Severe Sepsis or Septic Shock With Acute Kidney Injury
crrt - Severe Sepsis, Septic Shock
Phase 4UnknownAsan Medical Center602009-02-012009-02-05

Showing 20 of 25. Sign in to see all of them.

Narrower conditions

Shock, Septic (14)  ·  Diabetes Insipidus (4)  ·  Multiple Organ Failure (4)  ·  Sepsis (4)  ·  Cytokine Release Syndrome (2)  ·  Shock, Cardiogenic (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Acidosis (1)  ·  Acute Kidney Injury (1)  ·  Acute-On-Chronic Liver Failure (1)  ·  Cardiomyopathies (1)  ·  Critical Illness (1)  ·  Heart Arrest (1)  ·  Heart Failure (1)

Broader conditions

Pathologic Processes (25)  ·  Pathological Conditions, Signs and Symptoms (25)  ·  Inflammation (17)  ·  Systemic Inflammatory Response Syndrome (15)  ·  Infections (14)  ·  Sepsis (10)  ·  Cardiovascular Diseases (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Heart Diseases (5)  ·  Kidney Diseases (5)  ·  Male Urogenital Diseases (5)  ·  Urogenital Diseases (5)  ·  Urologic Diseases (5)

Interventions

Norepinephrine (4)  ·  Dexmedetomidine (2)  ·  Ivabradine (2)  ·  Adrenal Cortex Hormones (1)  ·  Albumins (1)  ·  Angiotensin II (1)  ·  Botulinum Toxins, Type A (1)  ·  Capsules (1)  ·  Ceftriaxone (1)  ·  Continuous Renal Replacement Therapy (1)  ·  Control Groups (1)  ·  Dexamethasone (1)  ·  Drug and Narcotic Control (1)  ·  Etoposide (1)  ·  Fentanyl (1)

Sponsors

Southeast University, China (3)  ·  Asan Medical Center (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  Association Pour La Promotion A Tours De La Reanimation Medicale (1)  ·  Austin Health (1)  ·  Azienda Usl di Bologna (1)  ·  Hadassah Medical Organization (1)  ·  Hospital San Carlos, Madrid (1)  ·  Hospital Universitario Principe de Asturias (1)  ·  Hospital Universitario Ramon y Cajal (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Kingman Regional Medical Center (1)  ·  Loyola University (1)  ·  Medical University of Vienna (1)  ·  Oslo University Hospital (1)

Countries

China (4)  ·  France (2)  ·  Israel (2)  ·  Spain (2)  ·  United States (2)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Canada (1)  ·  Greece (1)  ·  India (1)  ·  Italy (1)  ·  Norway (1)  ·  Pakistan (1)  ·  South Korea (1)

Top investigators

Amir Herman, MD, PhD (1)  ·  Eugenia Raichlin, MD (1)  ·  Juli Benbenisty, MPH (1)  ·  Kevin Teoh, MD, MSc (1)  ·  Miguel Sanchez, MD, PhD (1)  ·  Nor'azim Mohd Yunos, MBBS (1)  ·  Peter Schenk, MD (1)  ·  Richard P Whitlock, MD, MSc (1)  ·  Salim Yusuf, MD, DPhil (1)  ·  Sven-Erik Ricksten, Professor (1)  ·  Tom Heier, Professor (1)  ·  Tyson Dietrich, PharmD (1)

Results publications

PMID 12794416, PMID 18305265, PMID 21545483, PMID 21705897, PMID 23073953, PMID 24794878, PMID 25004265, PMID 26460660, PMID 27483065, PMID 28666990, PMID 28820036, PMID 29600824, PMID 30833491, PMID 34605781, PMID 36018257, PMID 36416787

NIH funding

2008 (1), 2017 (1)